American Association for Cancer Research

SHERPA: Unknown

People

  1. Chandarlapaty
    Chandarlapaty
  2. Razavi
    Razavi
  3. Schram
    Schram
  4. Drilon
    Drilon
  5. Jhaveri
    Jhaveri
  6. Berger
    Berger
  7. Ladewig
    Ladewig
  8. Cai
    Cai
  9. Ladanyi
    Ladanyi
  10. Leslie
    Leslie

Groups

  1. Sloan Kettering Institute Postdocs (26)
  2. Department of Medicine (24)
  3. GSK Faculty (24)
  4. Solid Tumor Oncology Division (24)
  5. Hematology-Oncology Fellows (19)
  6. Human Oncology and Pathogenesis Program (19)
  7. Breast Medicine Service (18)
  8. Weinberg Fellows (16)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (12)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (12)
Search Within
  1. "Maurizio Scaltriti"
Formats
  1. Meeting Abstract (35)
  2. Journal Article (14)
Groups
  1. Sloan Kettering Institute Postdocs (26)
  2. Department of Medicine (24)
  3. GSK Faculty (24)
  4. Solid Tumor Oncology Division (24)
  5. Hematology-Oncology Fellows (19)
  6. Human Oncology and Pathogenesis Program (19)

More Groups

People
  1. Maurizio Scaltriti (49)
  2. Jose Baselga (20)
  3. Pedram Razavi (11)
  4. Sarat Chandarlapaty (11)
  5. David Hyman (10)
  6. Emiliano Cocco (9)

More People

Years
  1. 2022 (2)
  2. 2021 (6)
  3. 2020 (10)
  4. 2019 (10)
  5. 2018 (6)
  6. 2017 (1)

More Years

Publications
  1. Cancer Research (37)
  2. Clinical Cancer Research (12)

Results (49)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The oncogenic PI3K-induced transcriptomic landscape reveals key functions in splicing and gene expression regulation
    Journal Article

    Ladewig, E.; Michelini, F.; Jhaveri, K.; Castel, P.; Carmona, J.; Fairchild, L.; Zuniga, A. G.; Arruabarrena-Aristorena, A.; Cocco, E.; Blawski, R.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • High FGFR1–4 mRNA expression levels correlate with response to selective FGFR inhibitors in breast cancer
    Journal Article

    Sánchez-Guixé, M.; Hierro, C.; Jiménez, J.; Viaplana, C.; Villacampa, G.; Monelli, E.; Brasó-Maristany, F.; Ogbah, Z.; Parés, M.; Guzmán, M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Cell line-specific network models of ER(+) breast cancer identify potential PI3Kα inhibitor resistance mechanisms and drug combinations
    Journal Article

    Zañudo, J. G. T.; Mao, P.; Alcon, C.; Kowalski, K.; Johnson, G. N.; Xu, G.; Baselga, J.; Scaltriti, M.; Letai, A.; Montero, J.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Epigenetic mechanisms of endocrine therapy response in breast cancer
    Meeting Abstract

    Toska, E.; Xu, G.; Arruabarrena-Aristorena, A.; Scaltriti, M.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Genomic alterations in PIK3CA-mutated breast cancer result in mTORC1 activation and limit the sensitivity to PI3Kα inhibitors
    Journal Article

    Cai, Y.; Xu, G.; Wu, F.; Michelini, F.; Chan, C.; Qu, X.; Selenica, P.; Ladewig, E.; Castel, P.; Cheng, Y.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Men1611 is a PI3K α/β selective and δ sparing inhibitor with long-lasting antitumor activity in different genetic backgrounds of PIK3CA mutant breast cancer models
    Meeting Abstract

    Fiascarelli, A.; Carrisi, C.; Merlino, G.; Capano, S.; Bisignano, D.; Talucci, S.; Bressan, A.; Bellarosa, D.; Bigioni, M.; Scaltriti, M.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Solti-1903 hope: Real-world clinical practice study to assess the impact of using comprehensive genomic data on the next treatment decision making-choice in patients with locally advanced or metastatic breast cancer in Spain
    Meeting Abstract

    Casas, A.; Ciruelos, E.; Oliveira, M.; Saura, C.; Bellet, M.; Pernas, S.; Gavilá, J.; Muñoz, M.; Vidal, M.; Farré, B. G.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Phase I basket study of taselisib, an isoform-selective PI3K inhibitor, in patients with PIK3CA-mutant cancers
    Journal Article

    Jhaveri, K.; Chang, M. T.; Juric, D.; Saura, C.; Gambardella, V.; Melnyk, A.; Patel, M. R.; Ribrag, V.; Ma, C. X.; Aljumaily, R.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • UGP2 is a critical regulator of protein glycosylation in pancreatic cancer
    Meeting Abstract

    Wolfe, A. L.; Galeas, J.; Toska, E.; Zhou, Q.; Ku, A.; Koche, R. P.; Bandyopadhyay, S.; Lebrilla, C. B.; Scaltriti, M.; McCormick, F.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
    Meeting Abstract

    Vasan, N.; Razavi, P.; Johnson, J. L.; Shao, H.; Shah, H.; Antoine, A.; Ladewig, E.; Gorelick, A.; Lin, T. Y.; Toska, E.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: